header banner
WORLD, Coronavirus

Russia approves clinical trials for Chinese COVID-19 vaccine Ad5-Ncov - Ifax

MOSCOW, Dec 7: Russia has granted approval for clinical trials to be held for the Chinese COVID-19 vaccine Ad5-Ncov involving 8,000 volunteers, the Interfax news agency reported on Monday.
Vials labelled "COVID-19 Coronavirus Vaccine" are placed on dry ice in this illustration taken, December 4, 2020. REUTERS/Dado Ruvic/Illustration
By Reuters

MOSCOW, Dec 7: Russia has granted approval for clinical trials to be held for the Chinese COVID-19 vaccine Ad5-Ncov involving 8,000 volunteers, the Interfax news agency reported on Monday.


Related story

Curing corona


Ad5-nCoV is a vaccine candidate co-developed by CanSino Biologics and a Chinese military-backed research unit.

Related Stories
WORLD

15 vaccine clinical trials underway in Africa

WORLD

Russia ready to trial combined AstraZeneca, Sputni...

OPINION

Fighting Dengue menace

SOCIETY

Phase III clinical trials of three COVID-19 vaccin...

WORLD

AstraZeneca resumes UK trials of COVID-19 vaccine...